Marker Therapeutics, Inc. (MRKR)

1.41 -0.07 (-4.73%) USD  |  NASDAQ  |  Mar 02, 16:00
1.40 -0.01 (-0.71%) After-Hours: 20:00
More

Marker Therapeutics Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EPS GAAP Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
Neurocrine Biosciences, Inc. Upgrade